LSV Asset Management
COLL icon

LSV Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

LSV Asset Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.5M Sell
344,500
-700
-0.2% -$23.9K 0.02% 404
2026
Q1 		$11.4M Sell
345,200
-2,700
-0.8% -$114K 0.02% 383
2025
Q4 		$16.1M Buy
347,900
+1,300
+0.4% +$54.4K 0.04% 338
2025
Q3 		$12.1M Sell
346,600
-3,300
-0.9% -$115K 0.03% 378
2025
Q2 		$10.3M Sell
349,900
-34,155
-9% -$974K 0.02% 389
2025
Q1 		$11.5M Sell
384,055
-6,396
-2% -$195K 0.03% 379
2024
Q4 		$11.2M Sell
390,451
-60,800
-13% -$2.01M 0.03% 394
2024
Q3 		$17.4M Buy
451,251
+70,700
+19% +$2.52M 0.04% 336
2024
Q2 		$12.3M Hold
380,551
– – 0.03% 412
2024
Q1 		$14.8M Buy
380,551
+248,751
+189% +$8.7M 0.03% 376
2023
Q4 		$4.06M Buy
131,800
+56,500
+75% +$1.42M 0.01% 545
2023
Q3 		$1.68M Sell
75,300
-195,300
-72% -$4.45M ﹤0.01% 632
2023
Q2 		$5.82M Buy
270,600
+29,800
+12% +$677K 0.01% 504
2023
Q1 		$5.78M Buy
240,800
+3,100
+1% +$82.2K 0.01% 500
2022
Q4 		$5.51M Sell
237,700
-1,900
-0.8% -$38.3K 0.01% 499
2022
Q3 		$3.84M Sell
239,600
-117,900
-33% -$2.08M 0.01% 542
2022
Q2 		$6.33M Sell
357,500
-2,500
-0.7% -$42.1K 0.01% 479
2022
Q1 		$7.33M Sell
360,000
-1,800
-0.5% -$34K 0.01% 480
2021
Q4 		$6.76M Buy
361,800
+214,900
+146% +$4.19M 0.01% 504
2021
Q3 		$2.9M Buy
+146,900
New +$3.18M 0.01% 612

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

LSV Asset Management's COLL Position: Q2 2026 in Review

LSV Asset Management reduced its Collegium Pharmaceutical (COLL) stake by 0.2% in Q2 2026, selling an estimated $23.9K and leaving 344,500 shares worth $12.5M. The position accounts for 0.02% of the portfolio, ranked #404.

LSV Asset Management first reported a position in COLL in Q3 2021 and has held it in 20 quarters since. The position peaked at $17.4M in Q3 2024. 112 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • LSV Asset Management held 344,500 shares of Collegium Pharmaceutical worth $12.5M as of Q2 2026.
  • LSV Asset Management sold 700 Collegium Pharmaceutical shares in Q2 2026, an estimated $23.9K.
  • Collegium Pharmaceutical made up 0.02% of LSV Asset Management's portfolio in Q2 2026, its #404 holding.
  • LSV Asset Management first reported a position in Collegium Pharmaceutical in Q3 2021 and has held it in 20 quarters since.
  • LSV Asset Management's Collegium Pharmaceutical position peaked at $17.4M in Q3 2024.
  • 112 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on LSV Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.